VTAK
Catheter Precision, Inc.2.1900
-0.0450-2.01%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
3.65MP/E (TTM)
0.06Basic EPS (TTM)
36.33Dividend Yield
0%Recent Filings
8-K
Secures $1.9M financing, buys air taxi
Catheter Precision signed a private placement for $1.853M in Series C-1 Preferred Stock, closing March 10, with up to $5.6M more in tranches pending stockholder approval by April 10 and SEC effectiveness. Deal funds legacy restructuring and working capital. Simultaneously agreed to acquire 80% of Flyte (air taxi operator) plus Ponderosa Air for $11.6M total—$776K cash now, $5M note, $5.8M Series D preferred. Aviation pivot adds FAA Part 135 ops, but needs approvals. Dilution risk looms large.
8-K
Swaps royalties for preferred stock
Catheter Precision swapped $9.5M net present value accrued royalties—owed to CEO David Jenkins and his FatBoy Capital—for 9,490 shares of new Series J Preferred Stock on February 12, 2026, terminating royalty rights as of December 31, 2025. Convertible into 6.1M common shares at $1.56 (matching year-end close), but only post-NYSE American stockholder approval. Balance sheet cleans up nicely. Related liabilities convert too.
8-K
Private placement and Flyte stake
Catheter Precision inked a private placement on February 6, 2026, for $2.18M in common stock and Series C-1 preferred, plus up to $3.23M more in Series C-2/C-3 tranches and $39M optional Series C-4, all at 80% of VWAP with $0.35 floor. It also swapped for 19.98% of Flyte equity valued at $5.25M via Series D preferred. Proceeds repay debt, restructure catheter ops, cut burn. Stockholder vote needed.
8-K
Extends $1.5M notes to 2029
Catheter Precision extended maturity on $1.5M in 8% short-term promissory notes held by CEO David Jenkins and affiliates, pushing deadlines to January 31, 2029 for most but 2028 for the Trust—easing near-term cash pressure. Related-party ties run deep: Jenkins controls FatBoy and founded the Trust. Notes stay restricted.
IPO
Employees
Sector
Industry
CLPT
ClearPoint Neuro Inc.
13.82+1.44
CV
CapsoVision, Inc.
12.00-1.78
CVRX
CVRx, Inc.
8.32+0.14
EBRCZ
EBR SYSTEMS INC NPV CDI 1:1
0.60+0.00
EW
Edwards Lifesciences Corporatio
85.32+1.94
HSCS
HeartSciences Inc.
2.31-0.16
MDNC
MEDINOTEC INC
5.00+0.00
MDT
Medtronic plc.
97.72-0.85
RBOT
Vicarious Surgical Inc.
2.43-0.04
VYCO
Vycor Medical, Inc.
0.16+0.00